The global Multiplex Immunofluorescence (mIF) Technology market was valued at US$ 1693 million in 2025 and is anticipated to reach US$ 2337 million by 2032, at a CAGR of 4.7% from 2026 to 2032.

Multiplex Immunofluorescence (mIF) Technology Market

Multiplex Immunofluorescence (mIF) Technology is an advanced in-situ detection technology that enables simultaneous specific labeling, visualization and quantitative analysis of multiple target antigens in a single tissue section (FFPE or fresh) via fluorescent-labeled specific antibodies, integrating fluorophore spectral matching, signal amplification (e.g., TSA technology) and high-resolution imaging systems. It overcomes the limitation of traditional single immunofluorescence in target quantity, preserves the original tissue microenvironment, realizes spatial localization and co-expression analysis of multiple biomarkers, and provides high-dimensional data support for biological mechanism research and clinical detection by leveraging key fluorophore properties such as brightness, photostability and Stokes shift.

The North American market for Multiplex Immunofluorescence (mIF) Technology is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Multiplex Immunofluorescence (mIF) Technology is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Multiplex Immunofluorescence (mIF) Technology in Tumor Immunology Research is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Multiplex Immunofluorescence (mIF) Technology include Eureka Biotech, ICON plc, Discovery Life Sciences, Precision Medicine Group, Terry Technologies, MGI Tech, panovue, Biospective, iCuraDx, Yucebio, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Multiplex Immunofluorescence (mIF) Technology market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Multiplex Immunofluorescence (mIF) Technology. The Multiplex Immunofluorescence (mIF) Technology market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Multiplex Immunofluorescence (mIF) Technology market comprehensively. Regional market sizes by Type, by Application, by Fluorescence Channel Count, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Multiplex Immunofluorescence (mIF) Technology manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Multiplex Immunofluorescence (mIF) Technology Market Report

Report Metric	Details
Report Name	Multiplex Immunofluorescence (mIF) Technology Market
Accounted market size in 2025	US$ 1693 million
Forecasted market size in 2032	US$ 2337 million
CAGR	4.7%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Direct Labeling mIF Technology TSA-based Amplification mIF Technology Dual-amplification mIF Technology
Segment by Fluorescence Channel Count	Low-channel mIF Technology Medium-channel mIF Technology High-channel mIF Technology
Segment by Application	Tumor Immunology Research Clinical Pathological Diagnosis Immune Microenvironment Profiling Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Eureka Biotech, ICON plc, Discovery Life Sciences, Precision Medicine Group, Terry Technologies, MGI Tech, panovue, Biospective, iCuraDx, Yucebio, Flagship Biosciences, Lanterne Dx (LDX), Crown Bioscience
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Fluorescence Channel Count, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Multiplex Immunofluorescence (mIF) Technology companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Multiplex Immunofluorescence (mIF) Technology Market growing?

Ans: The Multiplex Immunofluorescence (mIF) Technology Market witnessing a CAGR of 4.7% during the forecast period 2026-2032.

What is the Multiplex Immunofluorescence (mIF) Technology Market size in 2032?

Ans: The Multiplex Immunofluorescence (mIF) Technology Market size in 2032 will be US$ 2337 million.

Who are the main players in the Multiplex Immunofluorescence (mIF) Technology Market report?

Ans: The main players in the Multiplex Immunofluorescence (mIF) Technology Market are Eureka Biotech, ICON plc, Discovery Life Sciences, Precision Medicine Group, Terry Technologies, MGI Tech, panovue, Biospective, iCuraDx, Yucebio, Flagship Biosciences, Lanterne Dx (LDX), Crown Bioscience

What are the Application segmentation covered in the Multiplex Immunofluorescence (mIF) Technology Market report?

Ans: The Applications covered in the Multiplex Immunofluorescence (mIF) Technology Market report are Tumor Immunology Research, Clinical Pathological Diagnosis, Immune Microenvironment Profiling, Other

What are the Type segmentation covered in the Multiplex Immunofluorescence (mIF) Technology Market report?

Ans: The Types covered in the Multiplex Immunofluorescence (mIF) Technology Market report are Direct Labeling mIF Technology, TSA-based Amplification mIF Technology, Dual-amplification mIF Technology

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Multiplex Immunofluorescence (mIF) Technology Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Direct Labeling mIF Technology

1.2.3 TSA-based Amplification mIF Technology

1.2.4 Dual-amplification mIF Technology

1.3 Market by Fluorescence Channel Count

1.3.1 Global Multiplex Immunofluorescence (mIF) Technology Market Size Growth Rate by Fluorescence Channel Count: 2021 vs 2025 vs 2032

1.3.2 Low-channel mIF Technology

1.3.3 Medium-channel mIF Technology

1.3.4 High-channel mIF Technology

1.4 Market by Application

1.4.1 Global Multiplex Immunofluorescence (mIF) Technology Market Growth by Application: 2021 vs 2025 vs 2032

1.4.2 Tumor Immunology Research

1.4.3 Clinical Pathological Diagnosis

1.4.4 Immune Microenvironment Profiling

1.4.5 Other

1.5 Assumptions and Limitations

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Global Multiplex Immunofluorescence (mIF) Technology Market Perspective (2021–2032)

2.2 Global Multiplex Immunofluorescence (mIF) Technology Growth Trends by Region

2.2.1 Global Multiplex Immunofluorescence (mIF) Technology Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Multiplex Immunofluorescence (mIF) Technology Historic Market Size by Region (2021–2026)

2.2.3 Multiplex Immunofluorescence (mIF) Technology Forecasted Market Size by Region (2027–2032)

2.3 Multiplex Immunofluorescence (mIF) Technology Market Dynamics

2.3.1 Multiplex Immunofluorescence (mIF) Technology Industry Trends

2.3.2 Multiplex Immunofluorescence (mIF) Technology Market Drivers

2.3.3 Multiplex Immunofluorescence (mIF) Technology Market Challenges

2.3.4 Multiplex Immunofluorescence (mIF) Technology Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Multiplex Immunofluorescence (mIF) Technology Players by Revenue

3.1.1 Global Top Multiplex Immunofluorescence (mIF) Technology Players by Revenue (2021–2026)

3.1.2 Global Multiplex Immunofluorescence (mIF) Technology Revenue Market Share by Players (2021–2026)

3.2 Global Top Multiplex Immunofluorescence (mIF) Technology Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Multiplex Immunofluorescence (mIF) Technology Revenue

3.4 Global Multiplex Immunofluorescence (mIF) Technology Market Concentration Ratio

3.4.1 Global Multiplex Immunofluorescence (mIF) Technology Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Multiplex Immunofluorescence (mIF) Technology Revenue in 2025

3.5 Global Key Players of Multiplex Immunofluorescence (mIF) Technology Head Offices and Areas Served

3.6 Global Key Players of Multiplex Immunofluorescence (mIF) Technology, Products and Applications

3.7 Global Key Players of Multiplex Immunofluorescence (mIF) Technology, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Multiplex Immunofluorescence (mIF) Technology Breakdown Data by Type

4.1 Global Multiplex Immunofluorescence (mIF) Technology Historic Market Size by Type (2021–2026)

4.2 Global Multiplex Immunofluorescence (mIF) Technology Forecasted Market Size by Type (2027–2032)

5 Multiplex Immunofluorescence (mIF) Technology Breakdown Data by Application

5.1 Global Multiplex Immunofluorescence (mIF) Technology Historic Market Size by Application (2021–2026)

5.2 Global Multiplex Immunofluorescence (mIF) Technology Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Multiplex Immunofluorescence (mIF) Technology Market Size (2021–2032)

6.2 North America Multiplex Immunofluorescence (mIF) Technology Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Multiplex Immunofluorescence (mIF) Technology Market Size by Country (2021–2026)

6.4 North America Multiplex Immunofluorescence (mIF) Technology Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Multiplex Immunofluorescence (mIF) Technology Market Size (2021–2032)

7.2 Europe Multiplex Immunofluorescence (mIF) Technology Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Multiplex Immunofluorescence (mIF) Technology Market Size by Country (2021–2026)

7.4 Europe Multiplex Immunofluorescence (mIF) Technology Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Multiplex Immunofluorescence (mIF) Technology Market Size (2021–2032)

8.2 Asia-Pacific Multiplex Immunofluorescence (mIF) Technology Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Multiplex Immunofluorescence (mIF) Technology Market Size by Region (2021–2026)

8.4 Asia-Pacific Multiplex Immunofluorescence (mIF) Technology Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Multiplex Immunofluorescence (mIF) Technology Market Size (2021–2032)

9.2 Latin America Multiplex Immunofluorescence (mIF) Technology Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Multiplex Immunofluorescence (mIF) Technology Market Size by Country (2021–2026)

9.4 Latin America Multiplex Immunofluorescence (mIF) Technology Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Multiplex Immunofluorescence (mIF) Technology Market Size (2021–2032)

10.2 Middle East & Africa Multiplex Immunofluorescence (mIF) Technology Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Multiplex Immunofluorescence (mIF) Technology Market Size by Country (2021–2026)

10.4 Middle East & Africa Multiplex Immunofluorescence (mIF) Technology Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Eureka Biotech

11.1.1 Eureka Biotech Company Details

11.1.2 Eureka Biotech Business Overview

11.1.3 Eureka Biotech Multiplex Immunofluorescence (mIF) Technology Introduction

11.1.4 Eureka Biotech Revenue in Multiplex Immunofluorescence (mIF) Technology Business (2021–2026)

11.1.5 Eureka Biotech Recent Development

11.2 ICON plc

11.2.1 ICON plc Company Details

11.2.2 ICON plc Business Overview

11.2.3 ICON plc Multiplex Immunofluorescence (mIF) Technology Introduction

11.2.4 ICON plc Revenue in Multiplex Immunofluorescence (mIF) Technology Business (2021–2026)

11.2.5 ICON plc Recent Development

11.3 Discovery Life Sciences

11.3.1 Discovery Life Sciences Company Details

11.3.2 Discovery Life Sciences Business Overview

11.3.3 Discovery Life Sciences Multiplex Immunofluorescence (mIF) Technology Introduction

11.3.4 Discovery Life Sciences Revenue in Multiplex Immunofluorescence (mIF) Technology Business (2021–2026)

11.3.5 Discovery Life Sciences Recent Development

11.4 Precision Medicine Group

11.4.1 Precision Medicine Group Company Details

11.4.2 Precision Medicine Group Business Overview

11.4.3 Precision Medicine Group Multiplex Immunofluorescence (mIF) Technology Introduction

11.4.4 Precision Medicine Group Revenue in Multiplex Immunofluorescence (mIF) Technology Business (2021–2026)

11.4.5 Precision Medicine Group Recent Development

11.5 Terry Technologies

11.5.1 Terry Technologies Company Details

11.5.2 Terry Technologies Business Overview

11.5.3 Terry Technologies Multiplex Immunofluorescence (mIF) Technology Introduction

11.5.4 Terry Technologies Revenue in Multiplex Immunofluorescence (mIF) Technology Business (2021–2026)

11.5.5 Terry Technologies Recent Development

11.6 MGI Tech

11.6.1 MGI Tech Company Details

11.6.2 MGI Tech Business Overview

11.6.3 MGI Tech Multiplex Immunofluorescence (mIF) Technology Introduction

11.6.4 MGI Tech Revenue in Multiplex Immunofluorescence (mIF) Technology Business (2021–2026)

11.6.5 MGI Tech Recent Development

11.7 panovue

11.7.1 panovue Company Details

11.7.2 panovue Business Overview

11.7.3 panovue Multiplex Immunofluorescence (mIF) Technology Introduction

11.7.4 panovue Revenue in Multiplex Immunofluorescence (mIF) Technology Business (2021–2026)

11.7.5 panovue Recent Development

11.8 Biospective

11.8.1 Biospective Company Details

11.8.2 Biospective Business Overview

11.8.3 Biospective Multiplex Immunofluorescence (mIF) Technology Introduction

11.8.4 Biospective Revenue in Multiplex Immunofluorescence (mIF) Technology Business (2021–2026)

11.8.5 Biospective Recent Development

11.9 iCuraDx

11.9.1 iCuraDx Company Details

11.9.2 iCuraDx Business Overview

11.9.3 iCuraDx Multiplex Immunofluorescence (mIF) Technology Introduction

11.9.4 iCuraDx Revenue in Multiplex Immunofluorescence (mIF) Technology Business (2021–2026)

11.9.5 iCuraDx Recent Development

11.10 Yucebio

11.10.1 Yucebio Company Details

11.10.2 Yucebio Business Overview

11.10.3 Yucebio Multiplex Immunofluorescence (mIF) Technology Introduction

11.10.4 Yucebio Revenue in Multiplex Immunofluorescence (mIF) Technology Business (2021–2026)

11.10.5 Yucebio Recent Development

11.11 Flagship Biosciences

11.11.1 Flagship Biosciences Company Details

11.11.2 Flagship Biosciences Business Overview

11.11.3 Flagship Biosciences Multiplex Immunofluorescence (mIF) Technology Introduction

11.11.4 Flagship Biosciences Revenue in Multiplex Immunofluorescence (mIF) Technology Business (2021–2026)

11.11.5 Flagship Biosciences Recent Development

11.12 Lanterne Dx (LDX)

11.12.1 Lanterne Dx (LDX) Company Details

11.12.2 Lanterne Dx (LDX) Business Overview

11.12.3 Lanterne Dx (LDX) Multiplex Immunofluorescence (mIF) Technology Introduction

11.12.4 Lanterne Dx (LDX) Revenue in Multiplex Immunofluorescence (mIF) Technology Business (2021–2026)

11.12.5 Lanterne Dx (LDX) Recent Development

11.13 Crown Bioscience

11.13.1 Crown Bioscience Company Details

11.13.2 Crown Bioscience Business Overview

11.13.3 Crown Bioscience Multiplex Immunofluorescence (mIF) Technology Introduction

11.13.4 Crown Bioscience Revenue in Multiplex Immunofluorescence (mIF) Technology Business (2021–2026)

11.13.5 Crown Bioscience Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

TSA

ICON

Discovery Life Sciences

Precision Medicine Group

List of Tables

Table 1. Global Multiplex Immunofluorescence (mIF) Technology Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Direct Labeling mIF Technology

Table 3. Key Players of TSA-based Amplification mIF Technology

Table 4. Key Players of Dual-amplification mIF Technology

Table 5. Global Multiplex Immunofluorescence (mIF) Technology Market Size Growth Rate by Fluorescence Channel Count (US$ Million): 2021 vs 2025 vs 2032

Table 6. Key Players of Low-channel mIF Technology

Table 7. Key Players of Medium-channel mIF Technology

Table 8. Key Players of High-channel mIF Technology

Table 9. Global Multiplex Immunofluorescence (mIF) Technology Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 10. Global Multiplex Immunofluorescence (mIF) Technology Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 11. Global Multiplex Immunofluorescence (mIF) Technology Market Size by Region (US$ Million), 2021–2026

Table 12. Global Multiplex Immunofluorescence (mIF) Technology Market Share by Region (2021–2026)

Table 13. Global Multiplex Immunofluorescence (mIF) Technology Forecasted Market Size by Region (US$ Million), 2027–2032

Table 14. Global Multiplex Immunofluorescence (mIF) Technology Market Share by Region (2027–2032)

Table 15. Multiplex Immunofluorescence (mIF) Technology Market Trends

Table 16. Multiplex Immunofluorescence (mIF) Technology Market Drivers

Table 17. Multiplex Immunofluorescence (mIF) Technology Market Challenges

Table 18. Multiplex Immunofluorescence (mIF) Technology Market Restraints

Table 19. Global Multiplex Immunofluorescence (mIF) Technology Revenue by Players (US$ Million), 2021–2026

Table 20. Global Multiplex Immunofluorescence (mIF) Technology Market Share by Players (2021–2026)

Table 21. Global Top Multiplex Immunofluorescence (mIF) Technology Players by Tier (Tier 1, Tier 2, and Tier 3), based on Multiplex Immunofluorescence (mIF) Technology Revenue, 2025

Table 22. Ranking of Global Top Multiplex Immunofluorescence (mIF) Technology Companies by Revenue (US$ Million) in 2025

Table 23. Global 5 Largest Players Market Share by Multiplex Immunofluorescence (mIF) Technology Revenue (CR5 and HHI), 2021–2026

Table 24. Global Key Players of Multiplex Immunofluorescence (mIF) Technology, Headquarters and Area Served

Table 25. Global Key Players of Multiplex Immunofluorescence (mIF) Technology, Products and Applications

Table 26. Global Key Players of Multiplex Immunofluorescence (mIF) Technology, Date of General Availability (GA)

Table 27. Mergers and Acquisitions, Expansion Plans

Table 28. Global Multiplex Immunofluorescence (mIF) Technology Market Size by Type (US$ Million), 2021–2026

Table 29. Global Multiplex Immunofluorescence (mIF) Technology Revenue Market Share by Type (2021–2026)

Table 30. Global Multiplex Immunofluorescence (mIF) Technology Forecasted Market Size by Type (US$ Million), 2027–2032

Table 31. Global Multiplex Immunofluorescence (mIF) Technology Revenue Market Share by Type (2027–2032)

Table 32. Global Multiplex Immunofluorescence (mIF) Technology Market Size by Application (US$ Million), 2021–2026

Table 33. Global Multiplex Immunofluorescence (mIF) Technology Revenue Market Share by Application (2021–2026)

Table 34. Global Multiplex Immunofluorescence (mIF) Technology Forecasted Market Size by Application (US$ Million), 2027–2032

Table 35. Global Multiplex Immunofluorescence (mIF) Technology Revenue Market Share by Application (2027–2032)

Table 36. North America Multiplex Immunofluorescence (mIF) Technology Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. North America Multiplex Immunofluorescence (mIF) Technology Market Size by Country (US$ Million), 2021–2026

Table 38. North America Multiplex Immunofluorescence (mIF) Technology Market Size by Country (US$ Million), 2027–2032

Table 39. Europe Multiplex Immunofluorescence (mIF) Technology Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 40. Europe Multiplex Immunofluorescence (mIF) Technology Market Size by Country (US$ Million), 2021–2026

Table 41. Europe Multiplex Immunofluorescence (mIF) Technology Market Size by Country (US$ Million), 2027–2032

Table 42. Asia-Pacific Multiplex Immunofluorescence (mIF) Technology Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 43. Asia-Pacific Multiplex Immunofluorescence (mIF) Technology Market Size by Region (US$ Million), 2021–2026

Table 44. Asia-Pacific Multiplex Immunofluorescence (mIF) Technology Market Size by Region (US$ Million), 2027–2032

Table 45. Latin America Multiplex Immunofluorescence (mIF) Technology Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Latin America Multiplex Immunofluorescence (mIF) Technology Market Size by Country (US$ Million), 2021–2026

Table 47. Latin America Multiplex Immunofluorescence (mIF) Technology Market Size by Country (US$ Million), 2027–2032

Table 48. Middle East & Africa Multiplex Immunofluorescence (mIF) Technology Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 49. Middle East & Africa Multiplex Immunofluorescence (mIF) Technology Market Size by Country (US$ Million), 2021–2026

Table 50. Middle East & Africa Multiplex Immunofluorescence (mIF) Technology Market Size by Country (US$ Million), 2027–2032

Table 51. Eureka Biotech Company Details

Table 52. Eureka Biotech Business Overview

Table 53. Eureka Biotech Multiplex Immunofluorescence (mIF) Technology Product

Table 54. Eureka Biotech Revenue in Multiplex Immunofluorescence (mIF) Technology Business (US$ Million), 2021–2026

Table 55. Eureka Biotech Recent Development

Table 56. ICON plc Company Details

Table 57. ICON plc Business Overview

Table 58. ICON plc Multiplex Immunofluorescence (mIF) Technology Product

Table 59. ICON plc Revenue in Multiplex Immunofluorescence (mIF) Technology Business (US$ Million), 2021–2026

Table 60. ICON plc Recent Development

Table 61. Discovery Life Sciences Company Details

Table 62. Discovery Life Sciences Business Overview

Table 63. Discovery Life Sciences Multiplex Immunofluorescence (mIF) Technology Product

Table 64. Discovery Life Sciences Revenue in Multiplex Immunofluorescence (mIF) Technology Business (US$ Million), 2021–2026

Table 65. Discovery Life Sciences Recent Development

Table 66. Precision Medicine Group Company Details

Table 67. Precision Medicine Group Business Overview

Table 68. Precision Medicine Group Multiplex Immunofluorescence (mIF) Technology Product

Table 69. Precision Medicine Group Revenue in Multiplex Immunofluorescence (mIF) Technology Business (US$ Million), 2021–2026

Table 70. Precision Medicine Group Recent Development

Table 71. Terry Technologies Company Details

Table 72. Terry Technologies Business Overview

Table 73. Terry Technologies Multiplex Immunofluorescence (mIF) Technology Product

Table 74. Terry Technologies Revenue in Multiplex Immunofluorescence (mIF) Technology Business (US$ Million), 2021–2026

Table 75. Terry Technologies Recent Development

Table 76. MGI Tech Company Details

Table 77. MGI Tech Business Overview

Table 78. MGI Tech Multiplex Immunofluorescence (mIF) Technology Product

Table 79. MGI Tech Revenue in Multiplex Immunofluorescence (mIF) Technology Business (US$ Million), 2021–2026

Table 80. MGI Tech Recent Development

Table 81. panovue Company Details

Table 82. panovue Business Overview

Table 83. panovue Multiplex Immunofluorescence (mIF) Technology Product

Table 84. panovue Revenue in Multiplex Immunofluorescence (mIF) Technology Business (US$ Million), 2021–2026

Table 85. panovue Recent Development

Table 86. Biospective Company Details

Table 87. Biospective Business Overview

Table 88. Biospective Multiplex Immunofluorescence (mIF) Technology Product

Table 89. Biospective Revenue in Multiplex Immunofluorescence (mIF) Technology Business (US$ Million), 2021–2026

Table 90. Biospective Recent Development

Table 91. iCuraDx Company Details

Table 92. iCuraDx Business Overview

Table 93. iCuraDx Multiplex Immunofluorescence (mIF) Technology Product

Table 94. iCuraDx Revenue in Multiplex Immunofluorescence (mIF) Technology Business (US$ Million), 2021–2026

Table 95. iCuraDx Recent Development

Table 96. Yucebio Company Details

Table 97. Yucebio Business Overview

Table 98. Yucebio Multiplex Immunofluorescence (mIF) Technology Product

Table 99. Yucebio Revenue in Multiplex Immunofluorescence (mIF) Technology Business (US$ Million), 2021–2026

Table 100. Yucebio Recent Development

Table 101. Flagship Biosciences Company Details

Table 102. Flagship Biosciences Business Overview

Table 103. Flagship Biosciences Multiplex Immunofluorescence (mIF) Technology Product

Table 104. Flagship Biosciences Revenue in Multiplex Immunofluorescence (mIF) Technology Business (US$ Million), 2021–2026

Table 105. Flagship Biosciences Recent Development

Table 106. Lanterne Dx (LDX) Company Details

Table 107. Lanterne Dx (LDX) Business Overview

Table 108. Lanterne Dx (LDX) Multiplex Immunofluorescence (mIF) Technology Product

Table 109. Lanterne Dx (LDX) Revenue in Multiplex Immunofluorescence (mIF) Technology Business (US$ Million), 2021–2026

Table 110. Lanterne Dx (LDX) Recent Development

Table 111. Crown Bioscience Company Details

Table 112. Crown Bioscience Business Overview

Table 113. Crown Bioscience Multiplex Immunofluorescence (mIF) Technology Product

Table 114. Crown Bioscience Revenue in Multiplex Immunofluorescence (mIF) Technology Business (US$ Million), 2021–2026

Table 115. Crown Bioscience Recent Development

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

Table 119. Authors List of This Report

List of Figures

Figure 1. Multiplex Immunofluorescence (mIF) Technology Picture

Figure 2. Global Multiplex Immunofluorescence (mIF) Technology Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Multiplex Immunofluorescence (mIF) Technology Market Share by Type: 2025 vs 2032

Figure 4. Direct Labeling mIF Technology Features

Figure 5. TSA-based Amplification mIF Technology Features

Figure 6. Dual-amplification mIF Technology Features

Figure 7. Global Multiplex Immunofluorescence (mIF) Technology Market Size Comparison by Fluorescence Channel Count (US$ Million), 2021–2032

Figure 8. Low-channel mIF Technology Features

Figure 9. Medium-channel mIF Technology Features

Figure 10. High-channel mIF Technology Features

Figure 11. Global Multiplex Immunofluorescence (mIF) Technology Market Size by Application (US$ Million), 2021–2032

Figure 12. Global Multiplex Immunofluorescence (mIF) Technology Market Share by Application: 2025 vs 2032

Figure 13. Tumor Immunology Research Case Studies

Figure 14. Clinical Pathological Diagnosis Case Studies

Figure 15. Immune Microenvironment Profiling Case Studies

Figure 16. Other Case Studies

Figure 17. Multiplex Immunofluorescence (mIF) Technology Report Years Considered

Figure 18. Global Multiplex Immunofluorescence (mIF) Technology Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 19. Global Multiplex Immunofluorescence (mIF) Technology Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 20. Global Multiplex Immunofluorescence (mIF) Technology Market Share by Region: 2025 vs 2032

Figure 21. Global Multiplex Immunofluorescence (mIF) Technology Market Share by Players in 2025

Figure 22. Global Multiplex Immunofluorescence (mIF) Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 23. The Top 10 and 5 Players Market Share by Multiplex Immunofluorescence (mIF) Technology Revenue in 2025

Figure 24. North America Multiplex Immunofluorescence (mIF) Technology Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. North America Multiplex Immunofluorescence (mIF) Technology Market Share by Country (2021–2032)

Figure 26. United States Multiplex Immunofluorescence (mIF) Technology Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Canada Multiplex Immunofluorescence (mIF) Technology Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Europe Multiplex Immunofluorescence (mIF) Technology Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Europe Multiplex Immunofluorescence (mIF) Technology Market Share by Country (2021–2032)

Figure 30. Germany Multiplex Immunofluorescence (mIF) Technology Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. France Multiplex Immunofluorescence (mIF) Technology Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. U.K. Multiplex Immunofluorescence (mIF) Technology Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Italy Multiplex Immunofluorescence (mIF) Technology Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Russia Multiplex Immunofluorescence (mIF) Technology Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Ireland Multiplex Immunofluorescence (mIF) Technology Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Asia-Pacific Multiplex Immunofluorescence (mIF) Technology Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Asia-Pacific Multiplex Immunofluorescence (mIF) Technology Market Share by Region (2021–2032)

Figure 38. China Multiplex Immunofluorescence (mIF) Technology Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Japan Multiplex Immunofluorescence (mIF) Technology Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. South Korea Multiplex Immunofluorescence (mIF) Technology Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Southeast Asia Multiplex Immunofluorescence (mIF) Technology Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. India Multiplex Immunofluorescence (mIF) Technology Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Australia & New Zealand Multiplex Immunofluorescence (mIF) Technology Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Latin America Multiplex Immunofluorescence (mIF) Technology Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Latin America Multiplex Immunofluorescence (mIF) Technology Market Share by Country (2021–2032)

Figure 46. Mexico Multiplex Immunofluorescence (mIF) Technology Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Brazil Multiplex Immunofluorescence (mIF) Technology Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Middle East & Africa Multiplex Immunofluorescence (mIF) Technology Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Middle East & Africa Multiplex Immunofluorescence (mIF) Technology Market Share by Country (2021–2032)

Figure 50. Israel Multiplex Immunofluorescence (mIF) Technology Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Saudi Arabia Multiplex Immunofluorescence (mIF) Technology Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. UAE Multiplex Immunofluorescence (mIF) Technology Market Size YoY Growth (US$ Million), 2021–2032

Figure 53. Eureka Biotech Revenue Growth Rate in Multiplex Immunofluorescence (mIF) Technology Business (2021–2026)

Figure 54. ICON plc Revenue Growth Rate in Multiplex Immunofluorescence (mIF) Technology Business (2021–2026)

Figure 55. Discovery Life Sciences Revenue Growth Rate in Multiplex Immunofluorescence (mIF) Technology Business (2021–2026)

Figure 56. Precision Medicine Group Revenue Growth Rate in Multiplex Immunofluorescence (mIF) Technology Business (2021–2026)

Figure 57. Terry Technologies Revenue Growth Rate in Multiplex Immunofluorescence (mIF) Technology Business (2021–2026)

Figure 58. MGI Tech Revenue Growth Rate in Multiplex Immunofluorescence (mIF) Technology Business (2021–2026)

Figure 59. panovue Revenue Growth Rate in Multiplex Immunofluorescence (mIF) Technology Business (2021–2026)

Figure 60. Biospective Revenue Growth Rate in Multiplex Immunofluorescence (mIF) Technology Business (2021–2026)

Figure 61. iCuraDx Revenue Growth Rate in Multiplex Immunofluorescence (mIF) Technology Business (2021–2026)

Figure 62. Yucebio Revenue Growth Rate in Multiplex Immunofluorescence (mIF) Technology Business (2021–2026)

Figure 63. Flagship Biosciences Revenue Growth Rate in Multiplex Immunofluorescence (mIF) Technology Business (2021–2026)

Figure 64. Lanterne Dx (LDX) Revenue Growth Rate in Multiplex Immunofluorescence (mIF) Technology Business (2021–2026)

Figure 65. Crown Bioscience Revenue Growth Rate in Multiplex Immunofluorescence (mIF) Technology Business (2021–2026)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions